Cullinan Therapeutics Earnings
NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
15.46-0.17 (-1.09%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.79
Cullinan Therapeutics earnings summary
Cullinan Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.79.
Summary generated from market data by MetaCap's automated system. Methodology